Diagnostic Advisory Board
Diagnostics
8
3
Voice-of-Customer Research
KOL Identification
AdBoards
Objective
A diagnostics company asked DeciBio to convene an advisory board (ad board) to help it position its relatively new somatic oncology genomic profiling product in an already competitive market
Our Approach
DeciBio recruited and coordinated the scheduling for 8 oncology KOLs (both oncologists and pathologists) for a 3-hour virtual ad board. With input from the client, DeciBio prepared the questionnaire and stimuli for the attendees and facilitated the discussion.
Outcome
DeciBio delivered a recording and written summary of the ad board discussion. The summary included key takeaways related to:
- Current use of genomic profiling assays in routine care
- Factors that drive test differentiation
- Evolution of current offering and potential future offerings
- Tradeoffs and differentiating features of various evolutions
- Competitor feedback and drivers of switching
- Perceived value of potential new features and ancillary offerings
Related Client Results
Cell Line Market 5-Year Forecast
Voice-of-Customer Research
Global Companion Diagnostic Guideline Mapping and Strategy
Biomarker and Diagnostics Strategy
Go-to-Market Strategy
Sequencing Technology Go-to-Market Strategy
Voice-of-Customer Research
Go-to-Market Strategy
Pricing Strategy
Competitive Analysis
